Neogenomics (NEO) Return on Capital Employed (2011 - 2026)
Neogenomics (NEO) reported Return on Capital Employed of 8.38% for Q1 2026, down 171.0% on a YoY basis from 11.8% in Q1 2025, and up 7.52% quarter-over-quarter from 9.06% in Q4 2025.
Neogenomics (NEO) Return on Capital Employed (2011 - 2026) Analysis & Trends
Neogenomics has reported Return on Capital Employed for 16 years, with the latest figure at 8.38% in Q1 2026.
- For the quarter ending Q1 2026, Return on Capital Employed fell 171.0% year-over-year to 8.38%; the trailing twelve-month figure through Mar 2026 stood at 8.38% (down 171.0% YoY), and the FY2025 full-year result was 8.21%, down 143.0% from the prior year.
- Return on Capital Employed for Q1 2026 stood at 8.38%, up from 9.06% in the prior quarter.
- The five-year high for Return on Capital Employed was 6.52% in Q1 2024, with the low at 10.23% in Q3 2022.
- Historically, Return on Capital Employed has averaged 8.14% across 5 years, with a median of 8.23% in 2025.
- Annual changes were most pronounced in 2022 — Return on Capital Employed sank 830 bps — and 2023, when it surged 298 bps.
- Neogenomics' Return on Capital Employed stood at 9.51% in 2022, then increased by 28 bps to 6.8% in 2023, then decreased by 1 bps to 6.88% in 2024, then slumped by 32 bps to 9.06% in 2025, then climbed by 8 bps to 8.38% in 2026.
- The last three Return on Capital Employed figures came in at 8.38% (Q1 2026), 9.06% (Q4 2025), and 9.4% (Q3 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | ROCE (Qtr) |
|---|---|---|---|---|---|
| 1 | Waters | 30,529.42 Bn | 30,528.96 Bn | 1.11 Bn | 4.82% |
| 2 | Thermo Fisher Scientific | 183.75 Bn | 180.50 Bn | 7.74 Bn | 8.12% |
| 3 | Danaher | 133.13 Bn | 127.43 Bn | 3.59 Bn | 6.26% |
| 4 | Idexx Laboratories | 46.14 Bn | 45.94 Bn | 722.74 Mn | 67.98% |
| 5 | Agilent Technologies | 38.20 Bn | 36.39 Bn | 990.00 Mn | 14.57% |
| 6 | Natera | 31.50 Bn | 30.40 Bn | 696.04 Mn | -3.63% |
| 7 | Iqvia Holdings | 31.34 Bn | 29.36 Bn | 1.36 Bn | 10.24% |
| 8 | Illumina | 24.51 Bn | 23.36 Bn | 721.00 Mn | 16.90% |
| 9 | Mettler Toledo International | 23.53 Bn | 23.47 Bn | 555.82 Mn | 45.73% |
| 10 | Neogenomics | 1.48 Bn | 1.33 Bn | 80.86 Mn | -8.38% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -8.38% |
| Dec 31, 2025 | -9.06% |
| Sep 30, 2025 | -9.40% |
| Jun 30, 2025 | -8.23% |
| Mar 31, 2025 | -6.67% |
| Dec 31, 2024 | -6.88% |
| Sep 30, 2024 | -6.86% |
| Jun 30, 2024 | -7.05% |
| Mar 31, 2024 | -6.52% |
| Dec 31, 2023 | -6.80% |
| Sep 30, 2023 | -7.25% |
| Jun 30, 2023 | -8.14% |
| Mar 31, 2023 | -8.59% |
| Dec 31, 2022 | -9.51% |
| Sep 30, 2022 | -10.23% |
| Jun 30, 2022 | -10.01% |
| Mar 31, 2022 | -8.81% |
| Dec 31, 2021 | -6.59% |
| Sep 30, 2021 | -3.96% |
| Jun 30, 2021 | -1.71% |